Cyclic di-GMP: the First 25 Years of a Universal Bacterial Second Messenger
Open accessThe DOI matches its Crossref record; 409 of the 409 references it cites were found in a registry or an index.
Abstract
SUMMARY: Twenty-five years have passed since the discovery of cyclic dimeric (3′→5′) GMP (cyclic di-GMP or c-di-GMP). From the relative obscurity of an allosteric activator of a bacterial cellulose synthase, c-di-GMP has emerged as one of the most common and important bacterial second messengers. Cyclic di-GMP has been shown to regulate biofilm formation, motility, virulence, the cell cycle, differentiation, and other processes. Most c-di-GMP-dependent signaling pathways control the ability of bacteria to interact with abiotic surfaces or with other bacterial and eukaryotic cells. Cyclic di-GMP plays key roles in lifestyle changes of many bacteria, including transition from the motile to the sessile state, which aids in the establishment of multicellular biofilm communities, and from the virulent state in acute infections to the less virulent but more resilient state characteristic of chronic infectious diseases. From a practical standpoint, modulating c-di-GMP signaling pathways in bacteria could represent a new way of controlling formation and dispersal of biofilms in medical and industrial settings. Cyclic di-GMP participates in interkingdom signaling. It is recognized by mammalian immune systems as a uniquely bacterial molecule and therefore is considered a promising vaccine adjuvant. The purpose of this review is not to overview the whole body of data in the burgeoning field of c-di-GMP-dependent signaling. Instead, we provide a historic perspective on the development of the field, emphasize common trends, and illustrate them with the best available examples. We also identify unresolved questions and highlight new directions in c-di-GMP research that will give us a deeper understanding of this truly universal bacterial second messenger.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 401–409 of 409
Zhou, X., Meng, X., & Sun, B. (2008) · Cell Research · doi:10.1038/cr.2008.67 · Cited by 36
Wang, H., Wu, J.-H., Ayala, J. C., Benítez, J. A., & Silva, A. J. (2011) · Journal of Bacteriology · doi:10.1128/jb.05166-11 · Cited by 34
Zhao, L., KuoLee, R., Harris, G., Tram, K., Yan, H., & Chen, W. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.03.024 · Cited by 31
Shang, F., Xue, T., Sun, H., Xing, L., Zhang, S., Yang, Z., Zhang, L., & Sun, B. (2009) · Infection and Immunity · doi:10.1128/iai.01405-08 · Cited by 31
Inside the complex regulation of Pseudomonas aeruginosa chaperone usher systems
Giraud, C., & de Bentzmann, S. (2011) · Environmental Microbiology · doi:10.1111/j.1462-2920.2011.02673.x · Cited by 29
A Novel Tetrameric PilZ Domain Structure from Xanthomonads
Li, T., Chin, K., Fung, K.-M., Yang, M., Wang, A. H. ‐., & Chou, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022036 · Cited by 27
Pu, M., & Wood, T. K. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.032 · Cited by 23
Liberman, J. A., & Wedekind, J. E. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.03.016 · Cited by 20
Gomelsky, M. (2011) · Journal of Bacteriology · doi:10.1128/jb.06695-11 · Cited by 8
Self-citation
Research works printed but not linked: 83
- 10.1128/9781555816667 · doi:10.1128/9781555816667
- 10.1142/9789812813503_0009 · doi:10.1142/9789812813503_0009
- AmikamD WeinhouseH GalperinMY. 2010. Moshe Benziman and the discovery of c-di-GMP, p 11–23. In WolfeAJ VisickKL (ed), The second messenger cyclic di-GMP. ASM Press, Washington, DC.
- 10.1038/157659b0 · doi:10.1038/157659b0
- 10.1046/j.1365-2958.1999.01358.x · DOI
- 10.1111/j.1574-6968.2001.tb10880.x · doi:10.1111/j.1574-6968.2001.tb10880.x · Paper page
- 10.1111/j.1574-6968.2001.tb10814.x · doi:10.1111/j.1574-6968.2001.tb10814.x · Paper page
- 10.1128/IAI.01762-06 · doi:10.1128/iai.01762-06
- 10.1111/j.1462-2920.2009.02097.x · doi:10.1111/j.1462-2920.2009.02097.x
- 10.1074/jbc.M808221200 · doi:10.1074/jbc.m808221200
- 10.1016/0014-5793(85)80706-7 · DOI
- 10.1016/j.jmb.2010.03.007 · doi:10.1016/j.jmb.2010.03.007
- TalR GelfandDH CalhoonRD Ben-BassatA BenzimanM WongHC. 2 June 1998. Cyclic di-guanylate metabolic enzymes. US patent 5,759,828.
- 10.1099/mic.0.2006/002824-0 · doi:10.1099/mic.0.2006/002824-0
- 10.1107/S090744491104039X · doi:10.1107/s090744491104039x
- 10.1021/jp066582 · doi:10.1021/jp066582
- 10.1128/JB.00327-09 · doi:10.1128/jb.00327-09
- 10.1021/bi901121w · DOI
- 10.1016/0168-9525(96)81420-X · doi:10.1016/0168-9525(96)81420-x
- 10.1074/jbc.M110.196220 · doi:10.1074/jbc.m110.196220
- 10.1073/pnas.88.12.5472 · doi:10.1073/pnas.88.12.5472
- 10.1128/jb.178.1.46-53.1996 · doi:10.1128/jb.178.1.46-53.1996
- 10.1002/pro.557 · doi:10.1002/pro.557
- 10.1002/prot.22330 · doi:10.1002/prot.22330
- 10.1111/j.1365-2958.2012.08015.x · doi:10.1111/j.1365-2958.2012.08015.x
- 10.1111/j.1365-2958.2011.07814.x · doi:10.1111/j.1365-2958.2011.07814.x
- 10.1128/JB.01173-09 · doi:10.1128/jb.01173-09
- 10.1016/j.mimet.2011.11.015 · doi:10.1016/j.mimet.2011.11.015
- 10.1073/pnas.0912839107 · doi:10.1073/pnas.0912839107
- 10.4161/viru.1.5.12487 · doi:10.4161/viru.1.5.12487
- 10.1073/pnas.86.18.6973 · doi:10.1073/pnas.86.18.6973
- RussellMH BibleAN FangX GoodingJ CampagnaS GomelskyM AlexandreG. Integration of the second messenger c-di-GMP into the chemotactic signaling pathway promotes sensory adaptation. mBio, in press.
- 10.1128/JB.184.19.5251-5260.2002 · doi:10.1128/jb.184.19.5251-5260.2002
- 10.1016/S0006-291X(03)01223-3 · doi:10.1016/s0006-291x(03)01223-3
- 10.1074/jbc.M510701200 · DOI
- 10.1111/j.1574-6968.2007.00803.x · doi:10.1111/j.1574-6968.2007.00803.x
- 10.1271/bbb.67.2652 · doi:10.1271/bbb.67.2652
- 10.1128/jb.145.1.583-595.1981 · doi:10.1128/jb.145.1.583-595.1981
- 10.1046/j.1365-294X.2003.01953.x · doi:10.1046/j.1365-294x.2003.01953.x
- 10.1016/j.micpath.2008.12.001 · doi:10.1016/j.micpath.2008.12.001
- 10.1111/j.1364-3703.2008.00495.x · doi:10.1111/j.1364-3703.2008.00495.x
- 10.1111/mmi.12000 · doi:10.1111/mmi.12000
- 10.4161/viru.1.5.12704 · doi:10.4161/viru.1.5.12704
- 10.1128/JB.01719-06 · doi:10.1128/jb.01719-06
- 10.1128/JB.00640-12 · doi:10.1128/jb.00640-12
- 10.1371/journal.ppat.1002719 · doi:10.1371/journal.ppat.1002719
- 10.1111/j.1365-2958.2010.07247.x · DOI
- 10.1016/j.cell.2008.02.045 · doi:10.1016/j.cell.2008.02.045
- 10.1128/JB.01460-10 · doi:10.1128/jb.01460-10
- 10.1128/IAI.00702-12 · DOI
- 10.1128/IAI.01337-07 · doi:10.1128/iai.01337-07
- 10.1128/JB.01593-08 · doi:10.1128/jb.01593-08
- 10.1128/IAI.05320-11 · doi:10.1128/iai.05320-11
- 10.1128/JB.01218-08 · doi:10.1128/jb.01218-08
- 10.1111/j.1365-2958.2010.07246.x · DOI
- 10.1111/j.1365-2958.2001.02315.x · doi:10.1111/j.1365-2958.2001.02315.x · Paper page
- 10.1093/nar/gkl684 · doi:10.1093/nar/gkl684
- 10.1021/bi101448t · doi:10.1021/bi101448t
- 10.1371/journal.pone.0052646 · DOI
- 10.1093/nar/10.18.5637 · doi:10.1093/nar/10.18.5637
- 10.1111/j.1574-6968.2006.00457.x · doi:10.1111/j.1574-6968.2006.00457.x
- 10.1080/15257770802554150 · doi:10.1080/15257770802554150
- 10.1016/j.bmcl.2011.12.039 · doi:10.1016/j.bmcl.2011.12.039
- 10.1016/S0014-5793(99)00036-8 · doi:10.1016/s0014-5793(99)00036-8
- 10.1128/AAC.49.8.3109-3113.2005 · DOI
- KaraolisDKR. 4 August 2009. Method for stimulating the immune, inflammatory or neuroprotective response. US patent 7,569,555.
- 10.1016/j.micinf.2011.09.002 · DOI
- 10.1016/S0040-4020(03)01045-7 · doi:10.1016/s0040-4020(03)01045-7
- 10.1093/nass/3.1.103 · doi:10.1093/nass/3.1.103
- 10.1021/ja0449832 · doi:10.1021/ja0449832
- 10.1055/s-2006-950361 · doi:10.1055/s-2006-950361
- 10.1039/b719423d · doi:10.1039/b719423d
- 10.1007/s12010-011-9294-z · doi:10.1007/s12010-011-9294-z
- 10.1016/0014-5793(90)80253-F · doi:10.1016/0014-5793(90)80253-f
- 10.1039/c0cc05432a · doi:10.1039/c0cc05432a
- 10.1039/c2mb05430b · doi:10.1039/c2mb05430b
- 10.1021/ja1091062 · doi:10.1021/ja1091062
- 10.1021/ac300415k · doi:10.1021/ac300415k
- 10.1002/cbic.201100557 · doi:10.1002/cbic.201100557
- 10.1080/07328318508056168 · DOI
- GomelskyM. 2010. The core pathway: diguanylate cyclases, phosphodiesterases, and c-di-GMP-binding proteins, p 37–56. In WolfeAJ VisickKL (ed), The second messenger cyclic di-GMP. ASM Press, Washington, DC.
- 10.1128/JB.00651-09 · DOI
- 10.1093/nar/15.5.2123 · doi:10.1093/nar/15.5.2123
Cited by
Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria
Hall, C. W., & Mah, T.-F. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux010 · Cited by 1,696
Corrales, L., Glickman, L. H., McWhirter, S. M., Kanne, D. B., Sivick, K. E., Katibah, G. E., Woo, S.-R., Lemmens, E., Banda, T., Leong, J. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.031 · Cited by 1,560
Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence
Moradali, M. F., Ghods, S., & Rehm, B. H. A. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00039 · Cited by 1,537
Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
The biofilm life cycle: expanding the conceptual model of biofilm formation
Sauer, K., Stoodley, P., Goeres, D. M., Hall-Stoodley, L., Burmølle, M., Stewart, P. S., & Bjarnsholt, T. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00767-0 · Cited by 1,404
Metadata
- Authors
- Römling, U., Galperin, M. Y., & Gomelsky, M.
- Venue
- Microbiology and Molecular Biology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2013-03
- Volume
- 77
- Issue
- 1
- Pages
- 1-52
- ISSN
- 1092-2172 (ISSN-L)
- 1098-5557
- OpenAlex
- W2132665880
- Cited by
- 1,700
- References
- 409
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.